Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of whi...

Full description

Bibliographic Details
Main Authors: Alexandra Kupke, Asisa Volz, Erik Dietzel, Astrid Freudenstein, Jörg Schmidt, Hosam Shams-Eldin, Sylvia Jany, Lucie Sauerhering, Verena Krähling, Michelle Gellhorn Serra, Christiane Herden, Markus Eickmann, Stephan Becker, Gerd Sutter
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
Ebola virus
Modified Vaccinia virus Ankara
vaccine
correlates of protection
nucleoprotein
glycoprotein
Online Access:https://www.mdpi.com/2076-393X/10/4/533

Internet

https://www.mdpi.com/2076-393X/10/4/533

Similar Items